HDV was discovered in patients infected with hepatitis B virus (HBV). It generally makes ... 74% base pairing to form an unbranched rod-like structure. The genome sequence shows no homology ...

the key source of replicating hepatitis B virus (HBV), and inactivating integrated HBV DNA in hepatocytes. “We are pleased to receive Fast Track designation from the FDA for PBGENE-HBV and ...

Turning briefly to our hepatitis B program ... that's in their label right now. So we are aiming for a chronic viral suppressive regimen. We think we can suppress the virus in the vast majority ...

Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical ...

Viral hepatitis is a leading cause of liver disease, liver cancer and liver transplant in the United States and is a focus of an annual national awareness campaign that occurs ...

Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. The three main types—Hepatitis A, B, ...

A pioneering study uncovers crucial immune dynamics in hepatitis B, offering new insights into how immune responses evolve ...

Get insights into Vir Biotechnology's Q1 2025 earnings call, including ECLIPSE Phase III trial progress, oncology updates, and financial highlights.

Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.